GeneHealth - Your precision medicine

Hartnup Disease

Disease Details

Family Health Simplified

Buy Membership

Description: Hartnup disease is a genetic disorder caused by abnormalities in the transport of certain amino acids in the kidneys and intestines, leading to a variety of skin and neurological symptoms.
Type: Hartnup disease is a metabolic disorder. It is inherited in an autosomal recessive manner.
Signs And Symptoms: Hartnup disease manifests during infancy with variable clinical presentation: failure to thrive, photosensitivity, intermittent ataxia, nystagmus, and tremor.Nicotinamide is necessary for neutral amino acid transporter production in the proximal renal tubules found in the kidney, and intestinal mucosal cells found in the small intestine. Therefore, a symptom stemming from this disorder results in increased amounts of amino acids in the urine.
Pellagra, a similar condition, is also caused by low nicotinamide; this disorder results in dermatitis, diarrhea, and dementia.Hartnup disease is a disorder of amino acid transport in the intestine and kidneys; otherwise, the intestine and kidneys function normally, and the effects of the disease occur mainly in the brain and skin. Symptoms may begin in infancy or early childhood, but sometimes they begin as late as early adulthood. Symptoms may be triggered by sunlight, fever, drugs, or emotional or physical stress. A period of poor nutrition nearly always precedes an attack. The attacks usually become progressively less frequent with age. Most symptoms occur sporadically and are caused by a deficiency of niacinamide. A rash develops on parts of the body exposed to the sun. Mental retardation, short stature, headaches, unsteady gait, and collapsing or fainting are common. Psychiatric problems (such as anxiety, rapid mood changes, delusions, and hallucinations) may also result.
Prognosis: Prognosis:

Hartnup disease generally has a good prognosis with proper management. Most individuals can lead normal lives with appropriate treatment and dietary adjustments. The condition often presents with episodes of symptoms such as skin rashes and neurological issues, which can be effectively managed with niacin supplements and a high-protein diet. Regular monitoring and early intervention can help prevent complications.
Onset: Hartnup disease typically has its onset in early childhood, often between infancy and the age of 10. However, symptoms can vary widely, and some individuals may not show noticeable signs until later in life.
Prevalence: Hartnup disease is a rare inherited metabolic disorder, with its exact prevalence not well-documented. Estimates suggest it occurs in roughly 1 in 30,000 to 1 in 100,000 people.
Epidemiology: Hartnup disease is a rare autosomal recessive disorder. It affects both males and females equally and is typically diagnosed in childhood. The exact prevalence is unknown, but it is considered rare, with an estimated incidence of less than 1 in 30,000 to 40,000 live births. The disease occurs worldwide and has been reported in various ethnic groups.
Intractability: Hartnup disease is not generally considered intractable. It is a rare genetic disorder that can often be managed effectively with proper treatment and lifestyle adjustments. The disease primarily affects the transport of certain amino acids in the kidneys and intestines. Symptoms can include skin rashes, neurological issues, and developmental delays, but these can usually be controlled with a high-protein diet, niacin or nicotinamide supplements, and avoidance of sun exposure. Regular monitoring and medical support are essential for managing symptoms effectively.
Disease Severity: Hartnup disease is generally considered to be mild with most individuals experiencing few or no symptoms. However, severe cases can occur, particularly if not managed properly, leading to skin rashes, cerebellar ataxia, and psychiatric issues. Nanotechnological applications (nan) are not commonly associated with the diagnosis or treatment of Hartnup disease.
Healthcare Professionals: Disease Ontology ID - DOID:1060
Pathophysiology: Hartnup disease is a genetic disorder caused by mutations in the SLC6A19 gene, which encodes a transporter protein responsible for the absorption of neutral amino acids, particularly tryptophan, in the kidneys and intestines. The defective transporter leads to decreased absorption and increased urinary excretion of these amino acids, resulting in symptoms such as pellagra-like skin rashes, neurological abnormalities, and rarely, psychiatric symptoms. The condition is typically managed with a high-protein diet and niacin supplements.
Carrier Status: Hartnup disease is an autosomal recessive disorder. Carrier status refers to individuals who have one normal allele and one mutated allele of the SLC6A19 gene. Carriers typically do not exhibit symptoms of the disease.
Mechanism: Hartnup disease is primarily caused by mutations in the SLC6A19 gene. This gene encodes a protein known as the sodium-dependent neutral amino acid transporter, which is responsible for the absorption of certain amino acids from the intestine and their reabsorption in the kidneys.

**Molecular Mechanisms:**

1. **Defective Transporter Protein:** Mutations in the SLC6A19 gene lead to a malfunctioning or absent transporter protein. This protein is crucial for the uptake of neutral amino acids, such as tryptophan, across the cell membranes in the intestines and kidneys.

2. **Amino Acid Malabsorption:** Due to the defective transporter, there is decreased absorption of these amino acids in the intestines, leading to lower levels in the blood and an increased excretion in the urine.

3. **Secondary Niacin Deficiency:** Tryptophan is a precursor for niacin (vitamin B3) synthesis. Reduced tryptophan absorption can thus lead to niacin deficiency, contributing to symptoms similar to pellagra, which include dermatitis, diarrhea, and neurological symptoms.

Understanding these molecular mechanisms is vital for diagnosing and managing Hartnup disease, which often involves dietary management to compensate for the defective amino acid transport.
Treatment: A high-protein diet can overcome the deficient transport of neutral amino acids in most patients. Poor nutrition leads to more frequent and more severe attacks of the disease, which is otherwise asymptomatic. All patients who are symptomatic are advised to use physical and chemical protection from sunlight: avoid excessive exposure to sunlight, wear protective clothing, and use chemical sunscreens with a SPF of 15 or greater. Patients also should avoid other aggravating factors, such as photosensitizing drugs, as much as possible. In patients with niacin deficiency and symptomatic disease, daily supplementation with nicotinic acid or nicotinamide reduces both the number and severity of attacks. Neurologic and psychiatric treatment is needed in patients with severe central nervous system involvement.
Compassionate Use Treatment: Hartnup disease is a rare autosomal recessive metabolic disorder affecting the absorption of non-polar amino acids, including tryptophan, from the intestines and kidneys. Currently, there are no specific "compassionate use" treatments designated for Hartnup disease, but various off-label and experimental approaches are considered to manage symptoms.

1. **Nicacin/Nicotinamide Supplementation:** Since tryptophan is a precursor for niacin (Vitamin B3), supplementation with niacin or nicotinamide can help address symptoms, particularly those related to pellagra-like dermatitis and neuropsychiatric issues.

2. **High-Protein Diet:** Increasing dietary protein intake can help compensate for the defective amino acid transport, as other pathways may facilitate the absorption of amino acids.

3. **Sun Protection:** Protective measures against sunlight are recommended, as photosensitivity can lead to worsening of the skin lesions.

4. **Amino Acid Supplements:** Broad-spectrum amino acid supplements may also be used to support overall nutrition and balance amino acid levels.

5. **Monitoring and Managing Complications:** Regular monitoring and management of complications such as infections, neuropsychiatric symptoms, or other nutritional deficiencies are crucial.

Research into other potential treatments is limited due to the rarity of the disease. Management typically focuses on symptom relief and nutritional support.
Lifestyle Recommendations: **Lifestyle Recommendations for Hartnup Disease:**

1. **Dietary Management:**
- **High-Protein Diet:** Increase intake of proteins, as this can help supply sufficient levels of amino acids that may be inadequately absorbed due to the condition.
- **Supplementation:** Include vitamin supplements, particularly niacin (vitamin B3) or nicotinamide, to prevent pellagra-like symptoms.
- **Avoid Simple Sugars:** Minimize simple sugars that can increase the risk of metabolic disturbances.

2. **Sun Protection:**
- Wear broad-spectrum sunscreen, hats, and protective clothing to prevent skin rashes and other sun-induced complications.

3. **Hydration:**
- Maintain adequate hydration to support overall cellular function and reduce the risk of kidney stones, which may be a complication.

4. **Regular Monitoring:**
- Regular follow-ups with healthcare providers to monitor nutritional status, growth parameters in children, and to manage any emerging symptoms.

5. **Stress Management:**
- Implement stress reduction techniques such as yoga, meditation, or other relaxation practices, as stress can exacerbate symptoms.

6. **Avoiding Certain Medications:**
- Avoid medications that could potentially interfere with amino acid absorption or exacerbate symptoms, based on physician advice.

7. **Education and Awareness:**
- Educate family members and caregivers about the condition and its management to ensure a supportive environment.
Medication: Hartnup disease primarily requires nutritional management rather than specific medication. The mainstays of treatment include a high-protein diet and supplemental nicotinamide or niacin to address deficiencies in tryptophan and niacin. In some cases, a dermatologist might recommend sunscreens for photosensitive skin to prevent rashes.
Repurposable Drugs: Hartnup disease is a rare genetic disorder involving the body's ability to absorb certain amino acids, particularly tryptophan. While there are no specific repurposable drugs widely recommended for treating Hartnup disease, management typically focuses on dietary adjustments and supplementation. Niacin (vitamin B3) or nicotinamide supplements can help manage symptoms, as tryptophan is a precursor for niacin synthesis. Maintaining a high-protein diet to offset malabsorption and avoiding prolonged sun exposure are also recommended strategies.
Metabolites: Hartnup disease is an inherited metabolic disorder affecting the transport of certain amino acids in the kidneys and intestines. Key metabolites involved in this condition include:

1. **Tryptophan**: Reduced absorption and increased excretion in urine.
2. **Other neutral amino acids**: Similarly affected, leading to increased urinary excretion and decreased blood levels.
3. **Serotonin**: Potentially affected due to tryptophan deficiency, as it is a precursor.
4. **Nicotinamide (or niacin)**: Deficiency may occur since tryptophan is a precursor for niacin biosynthesis.

Effective management often includes supplementation of niacin or nicotinamide to mitigate symptoms related to niacin deficiency.
Nutraceuticals: Hartnup disease is a rare genetic disorder affecting the absorption of certain amino acids in the kidneys and intestines. Nutraceuticals that may aid in the management of Hartnup disease include:

1. **Niacin (Vitamin B3) or Niacinamide**: Since the condition can lead to symptoms similar to pellagra due to impaired tryptophan absorption, supplementation with niacin can be beneficial.

2. **Multivitamins containing B-complex**: These can help to ensure adequate levels of other B vitamins, which may support general metabolic functions.

3. **Amino Acid Supplements**: Supplementing with essential amino acids, particularly those that are poorly absorbed due to the disease, might be necessary in some cases.

It is crucial to consult with a healthcare provider for personalized dietary and supplement advice tailored to the specific needs of someone with Hartnup disease.
Peptides: Hartnup disease is a rare genetic disorder affecting the absorption of nonpolar amino acids, particularly tryptophan, in the kidneys and intestines. The primary issue involves defective transport of these amino acids across cell membranes. This can lead to amino acid deficiencies, impacting the synthesis of crucial peptides and proteins in the body.

The term "nan" is not specifically related to Hartnup disease. If you are referring to nanotechnology or nanoparticles in the context of Hartnup disease, current treatments primarily focus on dietary management and supplementation rather than nanotechnology-based interventions.